Skip to content
Center for Reproductive Rights
Center for Reproductive Rights

Primary Menu

  • About
    • Overview
    • Center Leadership & Staff
    • Pro Bono Program
    • Creative Council
    • Annual Reports
    • Contact Us
    • Careers
    • Diversity, Equity and Inclusion
  • Work
    • Overview
    • Litigation
    • Legal Policy and Advocacy
    • Resources & Research
    • Recent Case Highlights
    • Landmark Cases
    • World’s Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Issues
    • Overview
    • Abortion
    • Adolescent Sexual and Reproductive Health and Rights
    • Assisted Reproduction
    • Contraception
    • Humanitarian Settings
    • Maternal Health
    • COVID-19
  • Regions
    • Overview
    • Africa
    • Asia
    • Europe
    • Latin America and the Caribbean
    • United States
    • Global Advocacy
  • News
    • Latest News
    • Center in the Spotlight
    • Events
    • Press Releases
    • Press Room
    • Newsletters
  • Resources
    • Resources & Research
    • World Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Act
    • Overview
    • Give
    • Act
    • Learn
  • Donate
    • Make a Gift Now
    • Be a Champion
    • Join the Advocates Council
    • Become a Major Donor
    • Give Through Your Donor-Advised Fund
    • Make a Gift In Honor
    • Attend an Event
    • Leave a Legacy
    • More Ways to Give
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn
Donate
icon-hamburger icon-magnifying-glass Donate
icon-magnifying-glass-teal

Emergency Contraception (EC): A Safe and Effective Way to Prevent Unplanned Pregnancy

Center for Reproductive Rights - Center for Reproductive Rights - search logo
search Close Close icon
Center for Reproductive Rights -
Menu Close Menu Close icon
Donate

Primary Menu

  • About
    • Overview
    • Center Leadership & Staff
    • Pro Bono Program
    • Creative Council
    • Annual Reports
    • Contact Us
    • Careers
    • Diversity, Equity and Inclusion
  • Work
    • Overview
    • Litigation
    • Legal Policy and Advocacy
    • Resources & Research
    • Recent Case Highlights
    • Landmark Cases
    • World’s Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Issues
    • Overview
    • Abortion
    • Adolescent Sexual and Reproductive Health and Rights
    • Assisted Reproduction
    • Contraception
    • Humanitarian Settings
    • Maternal Health
    • COVID-19
  • Regions
    • Overview
    • Africa
    • Asia
    • Europe
    • Latin America and the Caribbean
    • United States
    • Global Advocacy
  • News
    • Latest News
    • Center in the Spotlight
    • Events
    • Press Releases
    • Press Room
    • Newsletters
  • Resources
    • Resources & Research
    • World Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Act
    • Overview
    • Give
    • Act
    • Learn
  • Donate
    • Make a Gift Now
    • Be a Champion
    • Join the Advocates Council
    • Become a Major Donor
    • Give Through Your Donor-Advised Fund
    • Make a Gift In Honor
    • Attend an Event
    • Leave a Legacy
    • More Ways to Give
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn

Related Content

Issues:

Contraception, Emergency Contraception

Regions:

United States

Work:

Reporting on Rights

Type:

Publications, Fact Sheets

Follow the Center

Donate Now

Join Now

04.01.2006

Reporting on Rights Contraception United States Publications

Emergency Contraception (EC): A Safe and Effective Way to Prevent Unplanned Pregnancy

Justin Goldberg

Share this Story

  • facebook
  • Twitter
  • linkedin
  • Email id

It is estimated that over three million American women have unplanned pregnancies each year, and over half of these end in abortion. Emergency contraception (EC), sometimes called the “morning-after pill,” is an effective method of preventing unwanted pregnancy.1


EC is Safe and Effective to Use
EC prevents pregnancy via a course of hormonal contraceptive pills taken in one- or two-dose regimens. EC is most effective if the first dose is taken within 24 hours after unprotected sex, however, it can be effective up to 5 days after intercourse. If the regimen is started within 24 hours, EC can be 95% effective.


EC is well tolerated by most women, including those who have had trouble using oral contraceptives regularly. Reported side effects are generally mild, including headache, nausea and stomach discomfort, and vary with the brand used.


Because EC can be used at all stages of a woman’s menstrual cycle, its mode of action varies. After intercourse, EC may prevent pregnancy by preventing ovulation, blocking fertilization or possibly preventing implantation of a fertilized egg.


,









EC comes in two formulations:




  • Combined Emergency Contraceptive Pills – ordinary oral contraceptive pills containing estrogen and progestin hormones

    ,



  • Progestin-only Emergency Contraceptive Pills or “minipills” – regular oral contraceptive pills, taken in higher doses and containing progestin only. These have been used as EC for 30 years.



Today there is also a pre-packaged, specially-designated EC kit on the market, Plan B.



EC Is Not Abortion
According to both medical science and legal convention, pregnancy begins only after implantation of a fertilized egg in the uterus. EC therefore acts to prevent a pregnancy. Studies show that EC has no effect on established pregnancies.


,








EC is Not RU-486 or medical abortion. Unlike RU-486 (mifepristone), EC is not an abortifacient. EC prevent pregnancy after sexual intercourse, while RU-486 ends an unwanted pregnancy at an early stage.

Some extreme anti-choice groups oppose EC by equating it with abortion, which they also oppose. These groups are out of step with the mainstream medical community, and their views find almost no support in laws and policies at the state and federal level. The attacks against EC are unwarranted and must therefore be seen as part of an agenda to ban all contraceptives.


EC is Supported by the FDA and Medical Associations
The Food and Drug Administration (FDA) has deemed the use of EC safe and effective in the prevention of pregnancy. The Center for Reproductive Rights petitioned the FDA in 1994 on behalf of medical associations to improve access to EC. In response to the petition and other advocacy efforts, in 1997, the FDA announced that six brands of oral contraceptive pills were safe and effective for use as EC. This announcement put the FDA’s explicit “stamp of approval” on agency reviewed EC regimens. Since then, in 1999 the FDA also approved Plan B, oral contraceptive pills packaged, sold, and marketed specifically for use as EC.


Increasing Access to EC


Access to EC will improve nationwide if the FDA approves a change of status and makes EC available over-the-counter.
On January 21, 2005, the Center for Reproductive Rights filed suit against the Acting Commissioner of the Food and Drug Administration in federal court for failing to approve the emergency contraceptive product Plan B for over-the-counter status. On February 14, 2001, the Center had petitioned the FDA, on behalf of more than 70 medical, public health, and other organizations, to change the status of EC from prescription to over-the-counter, based on the fact that EC is safe and effective for use without a prescription. In 2003 and 2004, the company that manufactures Plan B also petitioned the FDA for over-the-counter status for EC. Both the American Medical Association and the American College of Obstetricians and Gynecologists approve of a change to over-the-counter status, recognizing that over-the-counter availability may be the only way for some women to obtain EC in time to prevent a pregnancy. EC is now available either over-the-counter or directly from a pharmacist in many countries, including Canada, France, Portugal, Great Britain, and Finland, and increasing availability is part of a world-wide trend .


Partnerships Between Healthcare Providers
Some states authorize certain pharmacists to prescribe medications pursuant to collaborative agreements with physicians or other healthcare professionals, clinics or HMOs. Pharmacists in these states may be able to develop collaborative agreements that will allow them to provide EC to particular patients without an individual prescription. For example, in the state of Washington, women are able to obtain EC from a pharmacist, avoiding a potentially costly and time-consuming visit to a physician’s office or hospital. From 1998 until June 2001 Washington pharmacists prescribed and filled nearly 35,600 prescriptions for EC. The project prevented an estimated 2000 pregnancies, of which about half would have ended in abortion. Through legislative and regulatory efforts, other states, including Alaska, California, Hawaii, Maine, Massachusetts, New Hampshire, New Mexico and Vermont, are establishing similar programs to improve access to EC.


Obstacles to Women’s Access to EC
Despite the recognized value of EC, EC is not always made available to women.


Refusal clauses (or so-called “conscience clauses”) are provisions in state and federal legislation that permit doctors, other medical personnel, and sometimes pharmacists, to refuse to perform any procedure or dispense medication that conflicts with the provider’s religious or moral beliefs. Advocates are exploring ways to reduce the scope of refusal clauses in order to protect access to EC and other reproductive health services, and to ensure that such provisions are not added to new laws.


Additionally, Catholic healthcare systems and other hospital networks also try to avoid providing EC in their hospitals, even to sexual assault survivors who seek treatment in their emergency rooms. As Catholic healthcare providers increasingly merge with their secular counterparts, the restrictions on access to the fullest range of reproductive health services become more and more troubling. Reproductive rights advocates in the states are working to pass legislation to ensure that all hospital emergency rooms that treat women after a sexual assault inform women about EC as part of this care and provide EC upon request.


A final obstacle to women’s access to EC is a lack of awareness about EC. For example, one study found that only 68% of women are aware that they can prevent pregnancy after intercourse, and only 6% have ever used EC.2 In order to increase awareness about EC, the U.S. Congress and state legislators are considering bills that would increase public awareness about EC and encourage healthcare providers to inform their patients about EC.


,



1 See e.g. Henshaw, Stanley K. Unintended Pregnancy in the United States, 30 Family Planning Perspectives 24-29, 46, (January/February 1998), see also Rachel K. Jones, Jacqueline E. Darroch and Stanley K. Henshaw, Contraceptive Use Among U.S. Women Having Abortions in 2000-2001, 34 Perspectives on Sexual and Reproductive Health (November/December, 2002) (estimating that EC is responsible for up to 43% of the 11% decline in abortion rates between 1994 & 2000).
2 See Kaiser Family Foundation/SELF magazine, National Survey of Women on their Sexual Health (June 2003), see generally Kate Zernike, Use of Morning-After Pill Rising and It May Go Over the Counter, New York Times, May 19, 2003, at A1.
















Related Posts

Shadow Report to the U.N. Human Rights Council on the Second Universal Periodic Review of the U.S.

Click the link below to download the Center’s shadow report to the U.N. Human Rights Council on its Universal Periodic...

Abortion, Other Barriers, Contraception, Funding for Reproductive Healthcare, Other Financial Barriers, Maternal Health, Access to Quality Care,United States, Accountability Bodies, United Nations,At the United Nations, Reporting on Rights

Briefing Paper: The Right to Contraceptive Information and Services for Women and Adolescents

Around the world, the unmet need for safe and effective contraceptive services is staggering: Roughly 215 million women in developing...

Abortion, Adolescent SRHR, Contraception, Funding for Reproductive Healthcare, Public Funding, Maternal Health,United States, Accountability Bodies, United Nations,At the United Nations, Engaging Policymakers, Around the World, Reporting on Rights
Briefing Paper: The Right to Contraceptive Information and Services for Women and Adolescents

Remarks to the Institute of Medicine Committee on Preventive Services for Women

"My name is Aram Schvey, and I serve as Policy Counsel at the Center for Reproductive Rights. The Center is...

Legal Restrictions, Other Barriers, Contraception, Emergency Contraception, Legal Restrictions, Funding for Reproductive Healthcare,United States,Engaging Policymakers, In the States (USA), In Washington D.C., Reporting on Rights

Sign up for email updates.

The most up-to-date news on reproductive rights, delivered straight to you.

Footer Menu

  • Careers
  • Privacy Policy
  • Contact Us

Center for Reproductive Rights
© (1992-2023)

Use of this site signifies agreement with our disclaimer and privacy policy.

Center for Reproductive Rights
This site uses necessary, analytics and social media cookies to improve your experience and deliver targeted advertising. Click "Options" or click here to learn more and customize your cookie settings, otherwise please click "Accept" to proceed.
OPTIONSACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThis cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_UA-6619340-11 minuteNo description
_gid1 dayThis cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.
_parsely_session30 minutesThis cookie is used to track the behavior of a user within the current session.
HotJar: _hjAbsoluteSessionInProgress30 minutesNo description
HotJar: _hjFirstSeen30 minutesNo description
HotJar: _hjid1 yearThis cookie is set by Hotjar. This cookie is set when the customer first lands on a page with the Hotjar script. It is used to persist the random user ID, unique to that site on the browser. This ensures that behavior in subsequent visits to the same site will be attributed to the same user ID.
HotJar: _hjIncludedInPageviewSample2 minutesNo description
HotJar: _hjIncludedInSessionSample2 minutesNo description
HotJar: _hjTLDTestsessionNo description
SSCVER1 year 24 daysThe domain of this cookie is owned by Nielsen. The cookie is used for online advertising by creating user profile based on their preferences.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
_fbp3 monthsThis cookie is set by Facebook to deliver advertisement when they are on Facebook or a digital platform powered by Facebook advertising after visiting this website.
fr3 monthsThe cookie is set by Facebook to show relevant advertisments to the users and measure and improve the advertisements. The cookie also tracks the behavior of the user across the web on sites that have Facebook pixel or Facebook social plugin.
IDE1 year 24 daysUsed by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
IMRID1 year 24 daysThe domain of this cookie is owned by Nielsen. The cookie is used for storing the start and end of the user session for nielsen statistics. It helps in consumer profiling for online advertising.
personalization_id2 yearsThis cookie is set by twitter.com. It is used integrate the sharing features of this social media. It also stores information about how the user uses the website for tracking and targeting.
TDID1 yearThe cookie is set by CloudFare service to store a unique ID to identify a returning users device which then is used for targeted advertising.
test_cookie15 minutesThis cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDurationDescription
adEdition1 dayNo description
akaas_MSNBC10 daysNo description
cookielawinfo-checkbox-functional1 yearThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-others1 yearNo description
geoEdition1 dayNo description
next-i18next1 yearNo description
SAVE & ACCEPT
Powered by CookieYes Logo
Scroll Up